David Healy. Univ. of California, $39.95 (328p) ISBN 978-0-520-27098-5
“We are quite literally taking drugs to save the lives of companies who have a greater interest in the vitality of the diseases they market drugs for than in our well-being,” argues British psychiatrist Healy (Let Them Eat Prozac) in this scathing critique of the $900 billion global pharmaceutical industry. Healy chronicles the rise of blockbuster drugs like Prozac and Vioxx and how drug companies hyped them while downplaying their hazards. He takes particular aim at the outsourcing to private companies of clinical drug trials, once the domain of the National Institutes of Health and academics and now a $30 billion industry. He is particularly incisive on how the drug industry distorts medical care by, say, encouraging the use of statins like Lipitor rather than advising patients to lose weight. But he seems contrarian in opposing chronic disease management because it provides drug companies the opportunity for long-term sales of drugs that manage, but do not cure, a condition. Still, Healy’s contrarian streak and sharpness make this a disturbing, well-documented indictment that echoes many others in recent years, and one worth heeding. Agent: Beverly Slopen, Beverly Slopen Literary Agency (Canada). (Mar.)
Reviewed on: 01/30/2012
Release date: 03/01/2012
Show other formats
Open Ebook - 320 pages - 978-0-520-95181-5
Paperback - 302 pages - 978-0-520-27576-8
Open Ebook - 1 pages - 978-1-283-36974-9
Stay ahead with
Tip Sheet!
Free newsletter: the hottest new books, features and more
Only $18.95/month for Digital Access
or $20.95 for Print+Digital Access!
Only $18.95/month for Digital Access
or $20.95 for Print+Digital Access!
Email Address


Log In Lost Password

PW has integrated its print and digital subscriptions, offering exciting new benefits to subscribers, who are now entitled to both the print edition and the digital editions of PW (online or via our app). For instructions on how to set up your accout for digital access, click here. For more information, click here.

The part of the site you are trying to access is now available to subscribers only. Subscribers: to set up your digital subscription with the new system (if you have not done so already), click here. To subscribe, click here.

Email with questions.

Not Registered? Click here.